Products for Research Use Only
RegisterLogin

Bimiralisib (PQR309)

CAT: 1568-C13629-25mgSize: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1568-C13629-25mgSize:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1225037-39-7
Target
PI3K
Applications
PI3K/Akt/mTOR
Smiles
C1COCCN1C2=NC (=NC (=N2) C3=CN=C (C=C3C (F) (F) F) N) N4CCOCC4
Molecular Formula
C17H20F3N7O2
Additionnal Information
Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.
Storage Conditions
3 years -20°C powder

Alternative Products

CatalogName
MBS3841303-01PQR309 (Bimiralisib)
S8738-01Bimiralisib (PQR309)
A15992-25PQR309 (Bimiralisib) 25mg
A15992-2PQR309 (Bimiralisib) 2mg
A15992-1PQR309 (Bimiralisib) 1mg
A15992-100PQR309 (Bimiralisib) 100mg
A15992-10mM-DPQR309 (Bimiralisib) 10mM * 1mL in DMSO
HY-12868-01Bimiralisib
GTR19164258-01PQR309
A15992-10PQR309 10mg

Popular Products